• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation (OMRF)

Discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Jobs
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • OMRF in the Media
    • OMRF News
    • OMRF Publications
    • OMRF Videos
  • Patients
    • Lupus (SLE)
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Syndrome
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Donor Events
    • Tax Credit
    • Gift Planning
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for Esmon

Esmon

OMRF enters into a license agreement with Shanghai RAAS Blood Products

February 13, 2018

OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.

Filed Under: News, Technology Ventures News Tagged With: Activated Protein C, agreement, americans, antibody, apc, approval, blood, blood clots, breakthrough, CDC, Charles, charles esmon, China, chuck esmon, deal, death, disorder, drug, Esmon, forbes, hemophilia, injuries, innovation, license, Manu Nair, new, news, newsok, novel, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, products, research, rights, scientist-news, sepsis, shanghai raas, technology, trauma, traumatic bleeding, treatment

OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases

July 24, 2017

This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.

Filed Under: News, Technology Ventures News Tagged With: acute pancreatitis, agreement, blood, business, Charles, charles esmon, chuck esmon, collaboration, company, death, discovery partnerships with academia, dpas, drug, Esmon, Florea, Florea Lupu, gsk, healthcare, histones, lung injury, Lupu, newsok, nonprofit, novel, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, organ damage, padmaja mehta-D-souza, partner, research, scientist-news, scientists, therapy, toxic, trauma

Venture capital, biotech execs converge on OMRF

April 8, 2015

Networking, lab tours highlight first OMRF BioVenture Forum

Filed Under: News, Research News Tagged With: AstraZeneca, biotech, BioVenture, BioVenture Forum, Charles, charles esmon, Congressman Tom Cole, Craig Wegner, Crescendo Bioscience, diagnostics, Esmon, Gene Liau, Gov Mary Fallin, Manu Nair, Nair, OMRF BioVenture Forum 2015, Pfizer, pharma, pharmaceutical, scientist-news, technology ventures, venture capital, William Hagstrom

OMRF researcher receives American Heart Association award

December 30, 2014

OMRF’s Charles Esmon was recognized by the AHA as a distinguished scientist.

Filed Under: News Tagged With: accolade, aha, american heart association, award, Ceprotin, Charles, charles esmon, chicago, coagulation biology, distinguished scientist, donor, Esmon, heart disease, honor, institute, lifetime achievement, llyod noble chair, medicine, nonprofit, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, ou, professor, research, science, scientist-news

OMRF shares in $23.8 million grant to research trauma

November 15, 2013

Trauma is a leading cause of death in people under age 34.

Filed Under: Diseases, Featured News, News, Research News Tagged With: blood, Charles, charles esmon, chuck esmon, clotting, coagulation, coagulopathy, Department of Defense, Esmon, Kenneth Mann, NHLBI, scientist-news, Stephen Wisniewski, TACTIC, Trans-Agency Consortium for Trauma-Induced Coagulopathy, trauma, traumatic injury

OMRF scientist takes aim at malaria

July 23, 2013

New research reveals a protein studied at OMRF plays a role in malarial stroke.

Filed Under: Diseases, Featured News, News, Research News Tagged With: Charles, charles esmon, clot, epcr, Esmon, malaria, malarial stroke, scientist-news, stroke

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 5
  • Go to Next Page »

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Charity navigator
United Way Give Smart OKC
Facebook Twitter YouTube Instagram Mail Linkedin
Administrator Log In